Crowcon Detection Instruments appoints global sales director

Graham Franklin gains promotion at gas detection specialist

Gas detection specialist Crowcon Detection Instruments has appointed Graham Franklin as director of global sales.

Franklin has held a number of senior positions at the Abingdon, Oxfordshire, UK based firm. He was most recently sales director for Europe and has also been service manager, USA sales manager and UK sales manager.

Crowcon is a subsidiary of Halma, a leading supplier of portable and fixed gas detection instruments.

You may also like

Regulatory

Crowcon Gas-Pro ensures safety in confined spaces

Gas detector is compact and has a clear display for easy reading
Regulatory

Pfizer and BioNTech’s COMIRNATY COVID-19 vaccine wins FDA approval for seniors and high-risk individuals

The COVID-19 vaccines by Pfizer and BioNTech are based on BioNTech’s proprietary mRNA technology and were developed by both companies
Regulatory

Roca secures EMA recognition of radiation maculopathy as a distinct indication and Orphan Drug Designation

Roca Therapeutics (Roca) announces the granting of Orphan Drug Designation (ODD) by the European Medicines Agency (EMA) for its lead clinical candidate, RCT002, to treat radiation maculopathy
Manufacturing

Suncombe launches compact pH neutralisation systems for labs and small facilities

Expanded SUNpH range delivers compliance and performance in space-limited settings
Regulatory

Filter manufacturer maintains official seal of approval for health and safety

Inspectors from health and safety standards body BSI have praised a process filter maker’s “thorough and well-organised approach” to workplace safety management
Manufacturing

One family’s journey from diagnosis to gene replacement therapy

How the Krueger family, supported by clinicians, researchers, and manufacturers, accelerated a novel treatment for ultra-rare NEDAMSS in just 14 months
Regulatory

WuXi Biologics Ireland receives EMA approval to manufacture an innovative biologic

This approval adds to WuXi Biologics’ multiple facilities, which have received EMA and FDA approvals for commercial manufacturing of the same product since 2023
Subscribe now